title: Low-dose pulse methylprednisolone is an effective therapy for severe SLE flares.
authors.forename: K O
authors.initials: KO
authors.lastname: Kong
authors.forename: H
authors.initials: H
authors.lastname: Badsha
authors.forename: T Y
authors.initials: TY
authors.lastname: Lian
authors.forename: C J
authors.initials: CJ
authors.lastname: Edwards
authors.forename: H H
authors.initials: HH
authors.lastname: Chng
mesh_terms: D000328:Adult; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007262:Infusions, Intravenous; D008180:Lupus Erythematosus, Systemic / Q000175:diagnosis* / Q000188:drug therapy* / Q000401:mortality; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage*; D008875:Middle Aged; D011446:Prospective Studies; D020551:Pulse Therapy, Drug; D012008:Recurrence; D018570:Risk Assessment; D012494:Sampling Studies; D012720:Severity of Illness Index; D015996:Survival Rate; D016896:Treatment Outcome
chemical_list: D008775:Methylprednisolone